First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Shares Climb 1.4% – Should You Buy?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) shares were up 1.4% during mid-day trading on Thursday. The company traded as high as GBX 2,553.50 and last traded at GBX 2,545.50. Approximately 1,925 shares changed hands during trading, a decline of 35% from the average session volume of 2,942 shares. The stock had previously closed at GBX 2,511.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Performance

The company has a market capitalization of £1.04 billion, a price-to-earnings ratio of -2,314.09 and a beta of 0.44. The company has a 50-day moving average price of GBX 2,472.69 and a 200-day moving average price of GBX 2,136.95.

About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content. The company operates under the brand name of Blackbird. The company was founded in 1998 and is based in London, the United Kingdom.

Further Reading

Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.